PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Midamerica Cancer Care, West Kansas City, Missouri.\', \'Department of Gastroenterology and Hepatology, University of Arkansas for Medical Sciences, Little Rock, Arkansas.\', \'Texas Tech University, Paul L Foster School of Medicine, El Paso, Texas.\', \'Department of Internal Medicine, Brookdale University Hospital and Medical Center, Brooklyn, New York.\', \'Division of Gastroenterology, Moses Taylor Hospital and Reginal Hospital of Scranton, Scranton, Pennsylvania.\', \'Division of Biostatistics and Epidemiology, Department of Molecular and Translational Medicine, Texas Tech University, Paul L Foster School of Medicine, El Paso, Texas.\', \'The Wright Center for Graduate Medical Education, Scranton, Pennsylvania, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1097/MEG.0000000000002013
?:hasPublicationType
?:journal
  • European journal of gastroenterology & hepatology
is ?:pmid of
?:pmid
?:pmid
  • 33252418
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Pre-hospitalization proton pump inhibitor use and clinical outcomes in COVID-19.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all